Advances in Clinical Chemistry, Volume 88, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. vii 6. Preface - p. ix 7. Chapter One: Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease - p. ix 8. Chapter Two: Extracellular vesicle-associated MMPs: A modulator of the tissue microenvironment - p. 33 9. Chapter Three: Probing the endogenous peptidomes of cancer for biomarkers: A new endeavor - p. 66 10. Chapter Four: Novel glomerular filtration markers - p. 89 11. Chapter Five: Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases - p. 119 12. Chapter Six: Emicizumab (ACE910): Clinical background and laboratory assessment of hemophilia A - p. 149 13. Index - p. 169
Advances in Clinical Chemistry, Volume 88, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. vii 6. Preface - p. ix 7. Chapter One: Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease - p. ix 8. Chapter Two: Extracellular vesicle-associated MMPs: A modulator of the tissue microenvironment - p. 33 9. Chapter Three: Probing the endogenous peptidomes of cancer for biomarkers: A new endeavor - p. 66 10. Chapter Four: Novel glomerular filtration markers - p. 89 11. Chapter Five: Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases - p. 119 12. Chapter Six: Emicizumab (ACE910): Clinical background and laboratory assessment of hemophilia A - p. 149 13. Index - p. 169
